Infectious diseases of respiratory system (COVID-19) research hub

Cysteamine in association with standard therapy for the treatment of hospitalized patients with COVID-19 pneumonia: phase 2 study on safety of a new antiviral and direct therapy on the host

This study looks at a new medicine called Cysteamine, given alongside usual hospital care, for people with severe COVID-19. We want to check if it's safe and how it affects the body, hoping to find new ways to treat the virus.